MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
SEPN Septerna
- 24.280
- +0.880+3.76%
Close Dec 20 16:00 ET
- 24.280
- 0.0000.00%
Post 16:36 ET
1.08BMarket Cap-54.32P/E (TTM)
24.690High20.609Low4.29MVolume23.400Open23.400Pre Close103.22MTurnover23.31%Turnover Ratio83.72P/E (Static)44.40MShares27.47052wk High-12.33P/B446.75MFloat Cap18.62052wk Low--Dividend TTM18.40MShs Float27.470Historical High--Div YieldTTM17.44%Amplitude18.620Historical Low24.070Avg Price1Lot Size
About Septerna Company
Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.
Company Profile
SymbolSEPN
Company NameSepterna
Listing DateOct 25, 2024
Issue Price18.00
Founded2019
CEODr. Jeffrey T. Finer, M.D.,PhD
MarketNASDAQ
Employees68
Fiscal Year Ends12-31
Address250 East Grand Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-338-3533
Websitehttp://www.septerna.com
Company Executives
- Name
- Position
- Salary
- Dr. Jeffrey T. Finer, M.D.,PhD
- Chief Executive Officer, President and Director
- 2.14M
- Liz Bhatt
- Chief Operating Officer
- 883.70K
- Dr. Jae B. Kim, M.D.
- Chief Medical Officer
- --
- Ran Xiao, C.F.A.
- Principal Accounting Officer, Interim Chief Financial Officer and Vice President of Finance and Business Operations
- --
- Samira Shaikhly
- Chief People Officer
- 742.54K
- Dr. Daniel Long, D.Phil.
- Senior Vice President, Drug Discovery
- 646.74K
- Dr. Uwe Klein, PhD
- Senior Vice President, Biological Sciences
- 578.53K
- Dr. Jeffrey K. Tong, PhD
- Chairman of the Board
- --
- Dr. Alan Ezekowitz, D.Phil.,MB.Ch.B.
- Director
- --
- Abraham Bassan
- Independent Director
- --
- Dr. Jake Sin, PhD
- Independent Director
- --
- Dr. Bernard Coulie, M.B.A.,M.D.,PhD
- Independent Director
- 100.42K
- Shalini Sharp
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
